Français | English

A group based on complementary expertise with multidisciplinary know-how

A range of integrated biotechnology solutions

A complete platform, from DNA to recombinant antibodies

News

IL1RAP, a therapeutic target for oncologic treatment

Date of publication : 31/07/2020

IL1-RAP, has been identified as a marker of interest in the context of CML treatments, activating NK cells and blocking tumour growth at the same time. Diaclone and Inserm teams  have been able to develop a CAR-T therapy to specifically target this biomarker, which has demonstrated great promise during preclinical studies.

Read more on Linked In

Discover Diaclone's new IL1RAP clones:

Anti-Human IL1RAP B-L43 Azide Free      
Anti-Human IL1RAP B-R58 Azide Free      
Anti-Human IL1RAP B-L43 Unconjugated      
Anti-Human IL1RAP B-R58 Unconjugated      

 

Another immuno-oncology target you would like to discuss?

Not fully aware of our complete immuno-oncology portfolio

Time to get in touch with the Diaclone team!

  • Diaclone ELISpot assays, tried and trusted by researchers worldwide
    Date of publication : 01/04/2021


    Diaclone ELISpots (Enzyme-Linked Immunospot Assays) are highly specific immunoassays for the analysis of cytokine and other soluble molecule production and secretion from T-cells at a single cell...

    Read more
  • Come and join our team!
    Date of publication : 11/03/2021

    As part of the development of its new GMP plasmid production unit, RD-Biotech is recruiting two new profiles:

    - Technician in Molecular Biology Bioproduction

    - Quality Control Manager

    For...

    Read more
  • RD-BIOTECH IS PLEASED TO ANNOUNCE THE SIGNATURE OF A PARTNERSHIP AGREEMENT WITH LUMINEX CORPORATION
    Date of publication : 25/02/2021
  • DIACLONE ELISpot Kits - A new format to meet your demands
    Date of publication : 25/02/2021
    The Diaclone ELISpot kit range is extended with a new 2 PLATE FORMAT Read more
  • RD-Biotech lauréate de l’appel à projet France Relance !
    Date of publication : 15/02/2021


    RD-Biotech lauréate de l’appel à projet France Relance !




     



     

    RD-BIOTECH, voit son projet de construction d’une unité de production...

    Read more
  • Diaclone Monoclonal Antibody Platform
    Date of publication : 05/02/2021
  • New at Diaclone! SARS-CoV-2 SPIKE GLYCOPROTEIN RBD VARIANTS
    Date of publication : 21/01/2021
  • Proud to have participated in the development of BioNTech’s COVID-19 vaccine
    Date of publication : 21/01/2021

    The entire RD-Biotech team is proud to have participated in the development of BioNTech’s COVID-19 vaccine and thank them for putting their trust in our...

    Read more
  • New at Diaclone - SARS-CoV-2 ELISA set
    Date of publication : 24/11/2020

    Diaclone continues to innovate and provide you with new research tools.

    Build your own serological assay with our new SARS-CoV-2 ELISA set.
    Contact Diaclone for more information...

    Read more
  • NEW AT DIACLONE!... RECOMBINANT HUMAN SARS-CoV-2 PROTEINS
    Date of publication : 15/10/2020
    Developed in our laboratories in France Read more
  • Covid-19 Toolbox of the mAbexperts group
    Date of publication : 05/08/2020
  • Anti-S1 Domain Spike Protein is now available at Diaclone
    Date of publication : 03/08/2020


    Ideal for your COVID-19 studies...

    The antibody Anti-SARS-CoV-2 Spike S1 Protein CR3022 recognizes the S1 domain of the SARS-CoV Spike protein (aa318-510) as well as SARS-CoV-2 (COVID-19)...

    Read more
  • IL1RAP, a therapeutic target for oncologic treatment
    Date of publication : 31/07/2020

    IL1-RAP, has been identified as a marker of interest in the context of CML treatments, activating NK cells and blocking tumour growth at the same time. Diaclone and Inserm teams  have been able...

    Read more
  • Do you know the real potential of AAV?
    Date of publication : 01/07/2020

    Revealing the full potential of Adeno Associated Virus thanks to molecular biology

    Adeno-associated virus (AAV) is a small and single-strand DNA virus. In 1960, this non-enveloped entity was...

    Read more
  • What you need to know about Exosomes
    Date of publication : 01/07/2020

    “Huge opportunities”. “Many hurdles”. “Enormous potential”...

    It's just an excerpt of the several terms you'll come across if you search for them on...

    Read more
  • Complete Proteome of COVID-19
    Date of publication : 15/06/2020

    Are you familiar with all the proteins of SARS-CoV-2?

    Read more on Linked In

    Are you working on any of these proteins?

    Which one would you like to see developed and validated?

    Contact...

    Read more
  • RD-Biotech supplier of murine monoclonal antibodies D1-25 and 1112-1, for the quantification of rabies virus by ELISA.
    Date of publication : 15/06/2020

    Signature of  license agreement with Institut Pasteur (France) and the Winstar Institute (USA). RD-Biotech becomes the supplier of the clones D1-25 and 1112-1 and now offers the antibody pair...

    Read more
  • Patients’ Immune Battle Against COVID-19
    Date of publication : 27/05/2020

    A brief review of the expected complications of CovId-19 infection.

    Read more on Linked In

    Diaclone offers a specific range of Antibodies, ELISA and ELISpot kits for COVID-19 research that can...

    Read more
  • Fast track your Covid-19 Research with Diaclone’s CYTOKINES
    Date of publication : 26/05/2020

    Diaclone manufactures essential tools for Cytokine Storm monitoring & Immunotherapy...

    Read more
  • RD-Biotech : Here to help you in your Covid-19 related research projects
    Date of publication : 28/04/2020
  • Essential tools for COVID-19 and Immunotherapy research
    Date of publication : 03/04/2020
  • depistage
    RD-BIOTECH is proud to produce the monoclonal antibodies used in the IVD RAPID TEST COVID-19 Ag Respi-Strip developed by CorisBioConcept!
    Date of publication : 03/04/2020

    RD-BIOTECH, a major French actor in the production of monoclonal antibodies and recombinant proteins, is proud to be a qualified Partner of the Belgian company  Coris BioConcept  regarding...

    Read more
  • Future
    The Future of Therapeutic Antibody Development
    Date of publication : 12/03/2020

    The mAbexperts team has developed strong expertise in molecular biology to help you generate new formats of monoclonal antibodies.

    Read more on LinkedIn



     

    mAbexperts is a group...

    Read more
  • Antibody Humanization
    Date of publication : 05/03/2020

    Many articles about antibodies refer to the term “humanization”.  

    But what does humanization mean? What technical approaches are used to carry out such a process? What are the...

    Read more
  • Diaclone is a partner in a major European project involving a dozen partners from the Besançon region.
    Date of publication : 21/08/2018

    Le Projet MiMédi

    MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"

    Au sein...

    Read more